Aldeyra Therapeutics

3 followers

‌

Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Industries

Pharmaceutical

Headquarters

Lexington, United States

Employees

11-50

Links

Org chart

Todd C. Brady

CEO & President

Todd C. Brady

Collapse

Christopher Pearson

Vice President, Commercial Development and Strategy

David J. Clark

Chief Medical Officer

David Noskowitz

Vice President, Regulatory Affairs

Lise L. Kjems

Vice President, Clinical Development

Stephen G. Machatha

Senior Vice President, Technical Operations

Nate Hornbach

Sr. Director, Market Access

Annalisa Webb

Assistant Controller

Lisa Chan

Senior Accountant

Teams

Leadership Team

6 members

Clinical and Commercial Development

5 members

Quality and Regulatory

3 members

Finance

2 members

Similar companies

Umoja Biopharma

3 followers

Royalty Pharma

3 followers

Bristol-Myers Squibb

197 followers

Walgreens Boots Alliance

107 followers

Lundbeck

34 followers

Omnicell

21 followers

Alnylam Pharmaceuticals

20 followers

Syneos Health

19 followers

Catalent

18 followers

Organon

17 followers

NYU Langone Health

14 followers

Explore companies